Surgery News
-
Cardior strengthens patent portfolio of miRNAs for the diagnosis and therapy of heart and kidney diseases
Hanover, Germany, November 1, 2018 - Cardior Pharmaceuticals GmbH, a company focused on the development of noncoding RNA (ncRNA) therapeutics for patients with myocardial infarction and heart failure, today announced it has acquired a portfolio of four microRNA (miRNA) patents from Bayerische Patentallianz GmbH (BayPAT). miRNAs are short pieces of ncRNA native to all human cells that act as ...
-
Vestech works with UTS students to develop novel navigation approach
Cryptych’s Precision Fiducial Screw, used in Australia and the United States to monitor computer navigation accuracy during spine surgery, was used to provide data to a team from University of Technology Sydney to assess the ability to quantify deformity correction in real time during surgery. The UTS team have developed an algorithm to take the navigation data derived using the Precision ...
-
ELIAS Animal Health Announces Positive Results in Treatment of Osteosarcoma in Dogs
ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in companion animals, announced results from its canine osteosarcoma immunotherapy trial at the 2018 Veterinary Cancer Society (VCS) Annual Conference. The study evaluating ELIAS’ Autologous Prescription Product, known as ECI® (ELIAS Cancer Immunotherapy) resulted in a median survival time ...
-
Orthocell Board Member Heralded for Lifelong Contribution to Orthopaedics
Orthocell Ltd (ASX: OCC) is today celebrating the lifelong achievements of Professor Lars Lidgren, a Swedish surgeon, researcher, entrepreneur and Orthocell board member, who has been awarded an honorary fellowship by the American College of Surgeons (ACS). Orthocell Managing Director, Paul Anderson, said the fellowship recognises significant milestones in Professor Lidgren’s career, ...
-
Gelmetix signs collaboration for development of Knee Osteoarthritis product
Stemmatters and Gelmetix have established an agreement to develop an innovative hydrogel based device for the treatment of cartilage lesions. The partnership established focuses on the pre-clinical development of the new device towards clinical studies in human patients and subsequent market authorization. The new medical device aims to ensure a significant advance in the treatment of ...
-
Centric Medical Announces 510(K) Clearance of the Saturn External Fixation System
Centric Medical, a division of Life Spine®, Inc., which focuses on developing surgical implants for the treatment of lower distal extremity pathology, announced today That the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the SATURN External Fixation System which consists of rings, struts, threaded rods, pins, wires and connectors intended to be used as a ...
-
Symberix Announces Non-Dilutive Funding Support for Lead Programs
Symberix, a preclinical stage company dedicated to the development of novel pharmaceutical treatments for lower gastrointestinal (GI) disorders, has been awarded three Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH), entered into a Research Collaboration Agreement with the NIH’s National Center for Advancing Translational Sciences (NCATS), and ...
-
Gauss Raises $20 Million in Series C From Northwell Health Softbank Ventures Korea for AI-Enabled Platform for the Operating Room
Gauss Surgical, an AI-driven healthcare technology company, raised $20 million in Series C funding from Northwell Health and SoftBank Ventures Korea, the global early-stage venture capital arm of SoftBank Group, as well as from the LS Polaris Innovation Fund and seven other leading US health systems. The proceeds of the round will be used to accelerate the adoption of its Triton platform in ...
-
Novel radiometry guided microwave ablation technology set to advance with National Institutes of Health Small Business Innovation Research Award
Flagstaff, Arizona – October 9, 2018 – Symple Surgical Inc. (SSI) announced today that we have received a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase I Grant Award totaling $225,000.00. This award will leverage the ongoing R&D and commercialization initiatives with Duke University to pursue the integration of radiometric thermal feedback ...
-
Colibri Heart Valve to Present Patient Follow-up Results from Clinical Feasibility Study of Second-Generation TAVI System at TCT
Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international, single-arm, open-label early feasibility study (EFS) of the Colibri transcatheter aortic valve implantation (TAVI) system will be presented at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place September 21-25, 2018 ...
-
Invizius named ‘Best Innovative MedTech’
Invizius, a University of Edinburgh spinout whose technology promises to improve the lives of millions of dialysis patients, has been named Best Innovative MedTech company at the prestigious OBN Awards. The company’s success in the awards, which have a high profile in the life sciences sector, follows on from a seed investment of £500,000 from Mercia Fund Managers in May 2018. ...
-
Synergy Biomedical Announces FDA Clearance of BIOSPHERE FLEX
Synergy Biomedical, LLC, a developer of innovative biomaterial products, announced today that it has received FDA 510(k) clearance of BIOSPHERE® FLEX and is targeting a launch in the 4th quarter of 2018. Based on Synergy’s BioSphere® Technology, BIOSPHERE® FLEX is composed of porous, bioactive glass granules combined with a porous collagen and sodium hyaluronate scaffold. The ...
-
VEO Ophthalmics Launches CUSTOMFLEX ARTIFICIALIRIS in the U.S.
VEO Ophthalmics, LLC, today announced the launch of the CUSTOMFLEX ® ARTIFICIALIRIS, the first iris prosthesis available in the United States. The surgically implanted device received FDA approval on May 30, 2018 for use in children and adults for the treatment of iris defects resulting from congenital aniridia, acquired defects or other conditions associated with a completely or partially ...
-
MedTech Innovator Names Sana Health as 2018 Global Competition Winner at The MedTech Conference
MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, today announced Sana Health as the winner of its 2018 global competition. The company was selected in a live audience vote on Sept. 25 at The MedTech Conference, powered by AdvaMed, in Philadelphia. Sana Health, a medical technology startup based in Boulder, Colo., is developing a non-invasive ...
By Strados Labs
-
Landmark Lipid-Rich Plaque (LRP) Study Results Demonstrate the Ability to Accurately Identify Patients and Plaques at Risk for Major Coronary Events
Infraredx, Inc., a pioneer in intravascular imaging for mapping coronary artery disease, presented late-breaking clinical trial results for its landmark Lipid-Rich Plaque (LRP) Study today at the 30th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation. Cardiovascular disease remains the number one cause of death globally, ...
-
Mercury Biomed Awarded $1.5M Phase II NIH Grant
Mercury Biomed, a company developing a novel approach to managing core body temperature, was awarded a $1.5 million non-dilutive Phase II Small Business Technology Transfer (STTR) grant through the National Institute of General Medical Sciences (NIGMS). The award (2 R42 GM119871-02) will enable Mercury to continue along the path toward commercialization of its first device, WarmSmart, a ...
-
BioTrace Medical Announces Key Events Featuring Tempo Lead at TCT 2018
BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the 30th annual Transcatheter Cardiovascular Therapeutics (TCT) conference, which will take place September 21-25 in San Diego. BioTrace Medical’s innovative Tempo Temporary Pacing Lead is designed for secure and stable pacing with the goal of reducing ...
-
Pediatric Sedation Outside the Operating Room Conference
September 14-16th 2018, Hilton Financial District Hotel, San Francisco AventaMed will exhibit at the “Pediatric Sedation Outside the Operating Room” Conference, come say hello at our booth and learn about the Solo TTD. If you would like to arrange to meet with a member of our team at this event, please contact info@aventamed.com ...
-
IlluminOss Medical Receives Clearance to Expand Clinical Indications in the U.S.
IlluminOss Medical, a privately held, commercial-stage medical device company focused on minimally invasive orthopedic fracture repair, today announced that the IlluminOss Photodynamic Bone Stabilization System has received additional clinical clearance and is now indicated by the U.S. Food and Drug Administration (FDA) for use in skeletally mature patients in the treatment of traumatic, ...
-
USRM Hires Senior VP of US & International Sales
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced Phil Posa has joined its executive management team as Senior Vice President of U.S. & International Sales. Posa, who brings more than 30 years of experience in the pharmaceutical, medical device and regenerative spaces, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you